2003
DOI: 10.1053/plac.2002.0949
|View full text |Cite
|
Sign up to set email alerts
|

Altered Placental Development in Interleukin-10 Null Mutant Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
33
0
3

Year Published

2006
2006
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 42 publications
(37 citation statements)
references
References 27 publications
1
33
0
3
Order By: Relevance
“…The explanation for this likely relates to placental structure and function, with IL-10 constraining development of the placental labyrinth compartment where maternal-fetal nutrient exchange occurs, partly through inhibiting vasodilation of the fetal-placental circulation (59). It is possible that an effect on placental blood flow underpins the failure of exogenous IL-10 administration to alleviate the LPS-induced fetal growth restriction seen in the current study.…”
Section: Discussionmentioning
confidence: 77%
See 2 more Smart Citations
“…The explanation for this likely relates to placental structure and function, with IL-10 constraining development of the placental labyrinth compartment where maternal-fetal nutrient exchange occurs, partly through inhibiting vasodilation of the fetal-placental circulation (59). It is possible that an effect on placental blood flow underpins the failure of exogenous IL-10 administration to alleviate the LPS-induced fetal growth restriction seen in the current study.…”
Section: Discussionmentioning
confidence: 77%
“…This effect might be elicited through IL-10 down-regulation of placental production of NO (28), a key regulator of vasodilation and hemodynamics of the fetal and placental vasculature thought to be critical in maintaining nutrient and oxygen delivery to the fetus (60). Although IL-10 can also influence cytotrophoblast differentiation and invasiveness, it seems unlikely that changes in cell composition would account for effects of IL-10 in the placenta late in pregnancy when its morphogenesis is complete (59). The lack of benefit of IL-10 treatment for fetal mass contrasts with previous experiments in rats where LPS-induced fetal growth restriction was alleviated with exogenous IL-10 supplied at similar doses (28,29).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…As mentioned previously, T reg play an important role in maintaining tolerance during pregnancy while suppressing the activity of inflammatory Th17 cells, which have been implicated in autoimmune tissue injury. Here it can be appreciated that IL-6 expression, the result of MIA, can promote the expression of Th17 cells while downregulating T reg expression compromising placental function while promoting a potential autoimmune response to the developing fetus [144,[149][150][151] . Observations of an increase in maternal antibodies against neuronal and lymphocytic markers in the serum of mothers of autistic children further strengthen this hypothesis, suggesting the involvement of a maternal immune response in precipitating this disorder [71,110] .…”
Section: Mia and The Placental Barriermentioning
confidence: 99%
“…Maternal serum IL-10 increased with further increase in pregnancy period. It has been indicated that Il-10 has a role in regulating placental development and programming (Roberts et al, 2003). Furthermore, the derived cytokine as IL-10 may be associated to normal human pregnancy and labor (Opsjłn et al, 1993).…”
Section: Discussionmentioning
confidence: 99%